8 1 13 10 14 05 1 8 1 14 05 15 00 1 7 31 13 10 14 05 1 7 31 14 05 15 00 1 The Diagnosis of Mood Disorders-Key Issues in DSM- and Prospects for DSM- Allen Frances Professor Emeritus at Duke University 7 31 16 30 17 25 1 21
8 1 10 30 11 25 8 1 10 30 11 25 2 3 7 31 9 00 11 30 1 2 3 NTT 22
7 31 9 00 11 30 2 1990 2008 7 31 15 00 17 00 3 23
8 1 9 00 11 30 1 AGES 8 1 15 00 17 00 1 24
NTT NTT 8 1 15 00 17 00 2 1018 25
7 31 9 00 11 00 3 / /3,675 7 31 9 00 11 00 CBT CBT 4 3 CBT CBT CBT CBT CBT 26
8 1 8 30 10 30 2 8 1 8 30 10 30 3 2004 2008 27
7 31 15 00 16 30 SCID 1 DSM-IV DSM-IV SCID SCID 7 31 15 00 17 30 2 4 28
8 1 9 00 11 10 4 up-to-date NTT 8 1 15 00 17 30 3 29
8 1 9 00 14 00 5 2007 3 30 12,000 1 2 5 9:00 9:10 9:05 9:15 9:15 9:35 30 9:35 9:40 1 9:40 10:05 10:05 10:15 Q&A 10:15 10:35 10:35 10:50 10:50 10:55 2 10:55 11:20 11:20 11:30 Q&A 11:30 11:50 11:50 12:30 12:30 12:35 3 12:35 13:00 13:00 13:10 Q&A 13:10 13:30 13:30 13:40 13:40 14:00 30
1 7
7 31 12 00 13 00 Choice of Antidepressant Treatment in Clinical Practice 1 Madhukar H. Trivedi Division of Mood Disorders, Department of Psychiatry, University of Texas, Southwestern Medical Center 7 31 12 00 13 00 7 31 12 00 13 00 2 3 7 31 12 00 13 00 4 8 1 12 00 13 00 1 33
8 1 12 00 13 00 3 8 1 12 00 13 00 SSRI 4 7 31 17 35 18 30 3 34
8 1 18 00 20 00 1 6 10 JCPTD JCPTD JCPTD 680 6 35
P1-01 SSRI 1,2 3 4 5 6 7 1 2 3 4 2 5 6 7 P1-02 P1-03 SSRI SNRI 1,2 2 1 2 P1-04 1,2 1 3 1,4 1,4 4 3 1 1 2 3 4 5 MP P1-05 P1-06 P1-07 1 1 1 2 1 2 P1-08 P1-09 Aripiprazole 39
P2-01 1 1 1 1 2 2 2 2 2 3 3 1 23 P2-02 2 1 1 1 2 2 2 2 2 3 3 1 23 P2-03 3 1 1 1 2 2 2 2 2 3 3 1 23 P2-04 3 1 2 3 2 1 2 NTT 3 P2-05 P2-06 P2-07 P2-08 CERVICAL DEPRESSION 1,2 1 1 1,2 2 2 1,2 3 1 1 1 2 3 40
P2-09 1 2 3 1 4 5 1 NTT 2 3 4 5 P2-10 SST 1 1 1 1 2 1 1 2 P2-11 1 2 1 1 3 4 4 5 5 1 1 2 3 4 5 P2-12 P2-13 P3-01 P3-02 1,2 3 1 2 3 P3-03 1 2 3 1,2 1 2 3 41
P3-04 P3-05 P3-06 1 2 3 3 4 6 7 2 12 3 4 5 67 P3-07 MCI P3-08 1 2 1 2 P3-09 JUMP 1,2 1,2 1,2 2 2 1,2 1 1,2 2 1 2 P3-10 Natural Killer JUMP 1 1,2 1,2 1,2 1,2 1 1 2 P3-11 JUMP 1 1,2 1,2 1,2 1,2 1 1 2 P3-12 DHEA-sJUMP 1 1,2 1,2 1,2 1,2 1,2 2 1 2 P3-13 Juntendo University Mood disorder Project JUMP 42
P3-14 JUMP 1,3 1,2 1,2 1,2 1 1,2 1,2 4 1,2 1 1 2 3 4 P3-15 comorbidity 1 1,2 1,3 2 12 3 P3-16 P3-17 MHPG 1,2 1,2 1 1 1 2 1 2 P3-18 P3-19 1 2 3 1 2 3 P3-20 P3-21 1 2 3 1 2 3 P3-22 Cotard 43
P3-23 Capgras P3-24 P3-25 1 2 2 2 2 1 2 P3-26 fmri 1 1 1 1 1 2 3 1 1 2 3 P3-27 OSAS OSAS 1 2 1 3 1 4 5 1 23 4 5 P4-01 1 2 4 2 2 3 1 2 3 4 P4-02 1 2 4 2 2 3 1 2 3 4 P4-03 P4-04 44
P4-05 JUMP 1,2 1,2 1,2 1 1 2 P4-06 3 P4-07 1 2 3 4 5 6 6 1 1 2 3 NTT 4 5 6 P4-08 1 2 3 4 1 2 3 4 / P5-01 1 2 1 2 P5-02 P5-03 NTT P5-04 1 2 1 1 1 NTT 2 NTT P5-05 45
P5-06 1 1,2 1 1 1 2 P6-01 Case-control cohort 1,2 2 3 4 5 6 2 1 2 3 4 5 6 P6-02 P6-03 1,2 1,2 1,2,3 12 3 P6-04 1 2 3 3 4 1 5 1 23 4 5 P6-05 P6-06 1 1 1 1 1 2 1 2 P6-07 46
P6-08 IT 1 1,2 1 3 1 2 3 P6-09 P6-10 1,2 1 1 3 1 2 3 P6-11 5 1 2 3 1 2 3 P7-01 1 P7-02 P7-03 1 P7-04 1,2 1 1 1 2 P7-05 1 1 1,2 1 2 47